Lymphoma Studies

Lymphoma
Newly Diagnosed T-Cell Lymphoma (18 Years and Older)

Study Number: SGN35-014
Protocol Title: ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
Status: Open
Principal Investigator: Miguel Islas-Ohlmayer, M.D.

To learn more, please call The Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form. 

 Lymphoma
Relapsed/Refractory Hodgkin’s Disease (18 Years and Older)

Study Number: SGN35-016
Protocol Title: Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
Status: Open
Principal Investigator: Miguel Islas-Ohlmayer, M.D.

To learn more, please call The Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form